Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Reappraisal of Vegf in the Pathogenesis of Kawasaki Disease

Bibliographic Data

ID15714712
AuthorsChun-Yu Chen (0000-0001-6213-0853, Chi Mei Medical Center), Shih‐Hui Huang (0000-0003-3570-9397, Fooyin University), Shih-Hui Huang (Fooyin University), Kuang‐Jen Chien (Kaohsiung Veterans General Hospital), Kuang-Jen Chien (Congenital Structural Heart Disease Center, Department of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung 813414, Taiwan), Tsung-Jen Lai (Kaohsiung Veterans General Hospital), Wei‐Hsiang Chang (0000-0002-4001-8382, National Cheng Kung University), Kai‐Sheng Hsieh (0000-0002-0294-9872, China Medical University), Kai-Sheng Hsieh (Department of Pediatrics, China Medical University Children’s Hospital, Taichung 40447, Taiwan), Ken‐Pen Weng (Kaohsiung Veterans General Hospital, corresponding author), Ken-Pen Weng (Congenital Structural Heart Disease Center, Department of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung 813414, Taiwan)
Year2022
Volume9
Issue9
Pages1343-1343
Publication date2022-09-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueChildren (JOURNAL)
Journal identifiersISSN: 2227-9067 • E-ISSN: 2227-9067
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/children9091343
PMID36138652
OpenAlexW4294151726
LanguageEN
References cited29

Vascular endothelial growth factor (VEGF) is an important factor in mediating the inflammation of Kawasaki disease (KD). The literature regarding the relationship between VEGF and KD is sparse. The purpose of this study was to investigate the correlation of VEGF and KD. In a prospective study of 42 Taiwanese KD patients (18.9 ± 12.2 months, M/F 22/20) treated with intravenous immunoglobulin (IVIG), a series of VEGF levels was measured from the acute to convalescent phases. KD patients were classified into two subgroups with (n =20) and without (n = 22) acute coronary artery lesions (CALs). Control samples were obtained from 30 febrile controls (19.1 ± 13.7 months, M/F 13/17). In KD patients, VEGF levels in the pre-IVIG acute phase were significantly higher than those in the subacute and convalescent phases (both p < 0.001). In KD patients with CALs, VEGF levels significantly increased immediately in the post-IVIG phase (p = 0.039), and then significantly decreased in the subacute phase (p = 0.002). KD patients with acute CALs had higher median VEGF levels than those without acute CALs from acute to convalescent phases. In the subacute phase, KD patients with acute CALs had significantly higher VEGF levels (p = 0.022) than those without acute CALs. Our data show that VEGF did not decrease after IVIG treatment, and increased significantly after IVIG treatment in KD patients with acute CALs in acute phase. VEGF might be related to the complications of CALs in KD patients

Cardiology · Disease · Kawasaki disease · Pathogenesis · Pathology · VEGF receptors · Cardiovascular Issues in Pregnancy · Coronary Artery Anomalies · Kawasaki Disease and Coronary Complications · Medicine · Cancer Research

  • Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment

    Open Access•Laurel R Singleton, Tetsuya Sano et al.•European Journal of Pediatrics•2006

  • Prediction Model for Diagnosis of Kawasaki Disease Using iTRAQ-Based Analysis

    Open Access•Ken‐Pen Weng, Sung‐Chou Li et al.•Children•2021

  • Desquamation in Kawasaki Disease

    Open Access•Ling‐Sai Chang, Ling-Sai Chang et al.•Children•2021

Citation velocityhistorical
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae